|
Dr. Reddy's Laboratories Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
96162.64 Cr.
|
P/BV
|
3.13
|
Book Value (Rs.)
|
368.50
|
|
52 Week High/Low (Rs.)
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
17.24
|
|
Bookclosure
|
28/10/2024
|
EPS (Rs.)
|
66.84
|
Div Yield (%)
|
0.69
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 335.22 | 271.47 | 131.57 | 117.67 | 122.22 |
| Diluted EPS (Rs.) | 334.59 | 270.90 | 131.21 | 117.34 | 121.99 |
| Cash EPS (Rs.) | 421.65 | 343.37 | 196.96 | 188.25 | 188.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1693.93 | 1397.72 | 1154.59 | 1060.20 | 938.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1693.93 | 1397.72 | 1154.59 | 1060.20 | 938.56 |
| Revenue From Operations / Share (Rs.) | 1679.32 | 1480.77 | 1294.78 | 1144.68 | 1053.97 |
| PBDIT / Share (Rs.) | 529.22 | 444.45 | 255.53 | 250.08 | 185.98 |
| PBIT / Share (Rs.) | 441.09 | 369.41 | 185.51 | 176.23 | 116.00 |
| PBT / Share (Rs.) | 430.83 | 360.83 | 179.75 | 170.40 | 110.08 |
| Net Profit / Share (Rs.) | 333.52 | 268.32 | 126.94 | 114.40 | 118.53 |
| NP After MI And SOA / Share (Rs.) | 334.41 | 270.55 | 131.16 | 117.28 | 121.90 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 31.51 | 30.01 | 19.73 | 21.84 | 17.64 |
| PBIT Margin (%) | 26.26 | 24.94 | 14.32 | 15.39 | 11.00 |
| PBT Margin (%) | 25.65 | 24.36 | 13.88 | 14.88 | 10.44 |
| Net Profit Margin (%) | 19.86 | 18.12 | 9.80 | 9.99 | 11.24 |
| NP After MI And SOA Margin (%) | 19.91 | 18.27 | 10.12 | 10.24 | 11.56 |
| Return on Networth / Equity (%) | 19.74 | 19.35 | 11.35 | 11.06 | 12.98 |
| Return on Capital Employeed (%) | 25.13 | 25.95 | 15.44 | 15.84 | 12.04 |
| Return On Assets (%) | 14.35 | 13.96 | 7.33 | 7.33 | 8.72 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.01 | 0.02 | 0.01 |
| Total Debt / Equity (X) | 0.05 | 0.04 | 0.16 | 0.15 | 0.11 |
| Asset Turnover Ratio (%) | 0.78 | 0.79 | 0.56 | 0.59 | 0.56 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.59 | 2.38 | 1.82 | 1.80 | 1.75 |
| Quick Ratio (X) | 1.92 | 1.81 | 1.30 | 1.24 | 1.26 |
| Inventory Turnover Ratio (X) | 0.80 | 0.84 | 0.85 | 1.03 | 0.92 |
| Dividend Payout Ratio (NP) (%) | 11.91 | 11.04 | 18.99 | 21.24 | 19.32 |
| Dividend Payout Ratio (CP) (%) | 9.43 | 8.64 | 12.38 | 13.03 | 12.27 |
| Earning Retention Ratio (%) | 88.09 | 88.96 | 81.01 | 78.76 | 80.68 |
| Cash Earning Retention Ratio (%) | 90.57 | 91.36 | 87.62 | 86.97 | 87.73 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 51.59 | 51.85 | 44.39 | 42.90 | 31.44 |
| Interest Coverage Ratio (Post Tax) (%) | 33.51 | 32.30 | 23.05 | 20.62 | 21.04 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 102592.50 | 76382.99 | 72310.86 | 75755.28 | 53384.50 |
| EV / Net Operating Revenue (X) | 3.66 | 3.10 | 3.36 | 3.98 | 3.05 |
| EV / EBITDA (X) | 11.62 | 10.32 | 17.01 | 18.20 | 17.27 |
| MarketCap / Net Operating Revenue (X) | 3.67 | 3.12 | 3.33 | 3.94 | 2.96 |
| Retention Ratios (%) | 88.08 | 88.95 | 81.00 | 78.75 | 80.67 |
| Price / BV (X) | 3.63 | 3.31 | 3.73 | 4.26 | 3.32 |
| Price / Net Operating Revenue (X) | 3.67 | 3.12 | 3.33 | 3.94 | 2.96 |
| EarningsYield | 0.05 | 0.05 | 0.03 | 0.02 | 0.03 |
